184882-22-2

Upstream product

• 38712-57-1 3-(3-nitro-phenyl)-2-oxo-propionic acid 
• 99-61-6 3-nitro-benzaldehyde 
• 57731-07-4 2-methyl-4-(3-nitrobenzylidene)-2-methyloxazol-5(4H)-one 
• 143815-55-8 2-hydroxy-3-(3-nitrophenyl)acrylic acid 
• 57731-07-4 4-(3-nitrobenzylidene)-2-methyloxazoline-5-one 

Downstream Products

• 921195-80-4 (±)-2-hydroxy-3-(3'-aminophenyl)propionic acid 

Relevant academic research and scientific papers

COMPOUNDS AND THEIR SALTS SPECIFIC TO THE PPAR RECEPTORS AND THE EGF RECEPTORS AND THEIR USE IN THE MEDICAL FIELD

The present invention relates to compounds comprising the general formula (I), in which R1 and R2, which may be identical or different, are selected from the group comprising —H or a linear or branched alkyl group having from 1 to 6 carbon atoms or togeth

Compounds and Their Salts Specific to the PPAR Receptors and the EGF Receptors and Their Use in the Medical Field

The present invention relates to compounds comprising the general formula (I), in which R1 and R2, which may be identical or different, are selected from the group comprising —H or a linear or branched alkyl group having from 1 to 6

Deracemisation of aryl substituted α-hydroxy esters using Candida parapsilosis ATCC 7330: Effect of substrate structure and mechanism

Candida parapsilosis ATCC 7330 was found to be an efficient biocatalyst for the deracemisation of aryl α-hydroxy esters (65-85% yield and 90-99% ee). A variety of aryl and aryl substituted α-hydroxy esters were synthesized to reflect steric and electronic effects on biocatalytic deracemisation. The mechanism of this biocatalytic deracemisation was found to be stereoinversion.